These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 19787153

  • 1. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
    Jobim FC, Xavier NL, Uchoa DM, Cruz DB, Saciloto M, Chemello N, Schwartsmann G.
    Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
    [Abstract] [Full Text] [Related]

  • 2. Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.
    Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R.
    Eur J Cancer; 2003 Sep; 39(13):1948-56. PubMed ID: 12932675
    [Abstract] [Full Text] [Related]

  • 3. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H, Ohgi S, Terada T.
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [Abstract] [Full Text] [Related]

  • 4. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 5. Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.
    Waszczykowska A, Podgórski M, Waszczykowski M, Gerlicz-Kowalczuk Z, Jurowski P.
    Int J Mol Sci; 2020 Nov 18; 21(22):. PubMed ID: 33218057
    [Abstract] [Full Text] [Related]

  • 6. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S, Li L, Lin JY, Lin H.
    World J Gastroenterol; 2003 May 18; 9(5):899-904. PubMed ID: 12717827
    [Abstract] [Full Text] [Related]

  • 7. Imbalance between Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Promotes Invasion and Metastasis of Head and Neck Squamous Cell Carcinoma.
    Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Popescu CR, Gheorghe DC.
    Clin Lab; 2017 Oct 01; 63(10):1613-1620. PubMed ID: 29035450
    [Abstract] [Full Text] [Related]

  • 8. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 01; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

  • 9. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
    Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC, Zeferino LC.
    BMC Cancer; 2020 Jul 15; 20(1):660. PubMed ID: 32669083
    [Abstract] [Full Text] [Related]

  • 10. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR, Zhang C, Chen CY, Zhang L, Wang LX, Wang BH, Liu XY, Zhang MZ.
    Zhonghua Zhong Liu Za Zhi; 2012 May 15; 34(5):369-73. PubMed ID: 22883459
    [Abstract] [Full Text] [Related]

  • 11. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T, Jiang CX, Li Y, Liu X.
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec 15; 38(12):824-8. PubMed ID: 20193458
    [Abstract] [Full Text] [Related]

  • 12. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ, Wei QY, Li MR, Zhang LQ, Liang QC.
    Ai Zheng; 2003 Sep 15; 22(9):968-73. PubMed ID: 12969531
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA, Bergin FG, Leaper DJ.
    Br J Surg; 2000 Sep 15; 87(9):1215-21. PubMed ID: 10971431
    [Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D, Hrynyschyn K, Pallua N.
    Plast Reconstr Surg; 2003 Oct 15; 112(5):1279-86. PubMed ID: 14504511
    [Abstract] [Full Text] [Related]

  • 15. MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival.
    Nakopoulou L, Tsirmpa I, Alexandrou P, Louvrou A, Ampela C, Markaki S, Davaris PS.
    Breast Cancer Res Treat; 2003 Jan 15; 77(2):145-55. PubMed ID: 12602913
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.
    Korompelis P, Piperi C, Adamopoulos C, Dalagiorgou G, Korkolopoulou P, Sepsa A, Antsaklis A, Papavassiliou AG.
    Clin Chem Lab Med; 2015 Aug 15; 53(9):1415-24. PubMed ID: 25470608
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
    Ondruschka C, Buhtz P, Motsch C, Freigang B, Schneider-Stock R, Roessner A, Boltze C.
    Pathol Res Pract; 2002 Aug 15; 198(8):509-15. PubMed ID: 12389993
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
    Boveland SD, Moore PA, Mysore J, Krunkosky TM, Dietrich UM, Jarrett C, Paige Carmichael K.
    Vet Ophthalmol; 2010 Mar 15; 13(2):81-90. PubMed ID: 20447025
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
    Munaut C, Noël A, Hougrand O, Foidart JM, Boniver J, Deprez M.
    Int J Cancer; 2003 Oct 10; 106(6):848-55. PubMed ID: 12918061
    [Abstract] [Full Text] [Related]

  • 20. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
    Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Daraï E.
    Int J Gynecol Cancer; 2006 Oct 10; 16(5):1911-7. PubMed ID: 17009991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.